139 related articles for article (PubMed ID: 15906769)
1. Therapeutic effects of ecabet sodium, an antiulcer drug, on dextran sodium sulfate-induced ulcerative colitis in rats.
Noto T; Yamada H; Inui T; Okuyama K; Watanable A; Kimura I; Nagasaki M
Dig Dis Sci; 2005 May; 50(5):922-7. PubMed ID: 15906769
[TBL] [Abstract][Full Text] [Related]
2. Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
Takagi T; Naito Y; Okuda T; Uchiyama K; Adachi S; Mizushima K; Handa O; Kokura S; Ichikawa H; Yoshikawa T
J Gastroenterol Hepatol; 2010 Jul; 25(7):1259-65. PubMed ID: 20594253
[TBL] [Abstract][Full Text] [Related]
3. Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis.
Monteleone G; Caprioli F
Curr Opin Investig Drugs; 2007 May; 8(5):423-8. PubMed ID: 17520872
[TBL] [Abstract][Full Text] [Related]
4. Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study.
Kono T; Nomura M; Kasai S; Kohgo Y
Am J Gastroenterol; 2001 Mar; 96(3):793-7. PubMed ID: 11280553
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of an antiulcer agent, ecabet sodium on colorectal carcinogenesis in rodents.
Yarimizu T; Mitamura T; Suzuki S; Sakamoto S
Oncol Rep; 1998; 5(5):1103-7. PubMed ID: 9683817
[TBL] [Abstract][Full Text] [Related]
6. Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.
Nakashima T; Maeda T; Nagamoto H; Kumakura T; Takai M; Mori T
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S124-31. PubMed ID: 16184415
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ecabet sodium enema on steroid resistant or steroid dependent ulcerative colitis.
Iizuka M; Itou H; Konno S; Shirasaka T; Horie Y; Shindo K; Watanabe S
Gut; 2006 Oct; 55(10):1523. PubMed ID: 16966708
[No Abstract] [Full Text] [Related]
8. Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats.
Kinoshita M; Iwasaki H; Yasoshima A; Tamaki H
Biol Pharm Bull; 1993 Dec; 16(12):1220-5. PubMed ID: 8130770
[TBL] [Abstract][Full Text] [Related]
9. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y
Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
[TBL] [Abstract][Full Text] [Related]
10. Induction of experimental acute ulcerative colitis in rats by administration of dextran sulfate sodium at low concentration followed by intracolonic administration of 30% ethanol.
Chen Y; Si JM; Liu WL; Cai JT; Du Q; Wang LJ; Gao M
J Zhejiang Univ Sci B; 2007 Sep; 8(9):632-7. PubMed ID: 17726744
[TBL] [Abstract][Full Text] [Related]
11. Effect of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats.
Kinoshita M; Noto T; Tamaki H
Biol Pharm Bull; 1995 Feb; 18(2):223-6. PubMed ID: 7742788
[TBL] [Abstract][Full Text] [Related]
12. Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
Okuyama K; Saito N; Kume E; Noto T; Nagasaki M
Inflammopharmacology; 2007 Apr; 15(2):90-4. PubMed ID: 17450449
[TBL] [Abstract][Full Text] [Related]
13. Ecabet sodium: a potential new agent in the management of distal colitis.
Lawrance IC
J Gastroenterol Hepatol; 2010 Jul; 25(7):1182-4. PubMed ID: 20594242
[No Abstract] [Full Text] [Related]
14. Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8.
Shimoyama T; Fukuda S; Liu Q; Nakaji S; Munakata A; Sugawara K
J Gastroenterol; 2001 Mar; 36(3):153-7. PubMed ID: 11291877
[TBL] [Abstract][Full Text] [Related]
15. Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro.
Furukawa O; Kume E; Sugamoto S; Kawauchi S; Takeuchi K
Digestion; 2000; 62(2-3):116-25. PubMed ID: 11025359
[TBL] [Abstract][Full Text] [Related]
16. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. II. Interaction with substrate protein.
Ito Y; Onoda Y; Nakamura S; Tagawa K; Fukushima T; Sugawara Y; Takaiti O
Jpn J Pharmacol; 1993 Jun; 62(2):175-81. PubMed ID: 8371516
[TBL] [Abstract][Full Text] [Related]
17. Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium.
Kinoshita M; Kume E; Tamaki H
J Pharmacol Exp Ther; 1995 Oct; 275(1):494-501. PubMed ID: 7562591
[TBL] [Abstract][Full Text] [Related]
18. Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats. Comparison with sucralfate.
Kinoshita M; Yamasaki K; Kokusenya Y; Tamaki H
Dig Dis Sci; 1995 Mar; 40(3):661-7. PubMed ID: 7895562
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of curcumin attenuates visceral hyperalgesia through inhibiting phosphorylation of TRPV1 in rat model of ulcerative colitis.
Yang M; Wang J; Yang C; Han H; Rong W; Zhang G
Mol Pain; 2017; 13():1744806917726416. PubMed ID: 28812431
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis.
Zhang ZL; Fan HY; Yang MY; Zhang ZK; Liu K
World J Gastroenterol; 2014 Nov; 20(41):15310-8. PubMed ID: 25386079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
